Cambridge Investment Research Advisors
AGN

Cambridge Investment Research Advisors’s Allergan Inc AGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,996
Closed -$1.7M – 1491
2014
Q4 		$1.7M Buy
7,996
+164
+2% +$32.6K 0.05% 324
2014
Q3 		$1.4M Buy
7,832
+378
+5% +$62.8K 0.04% 410
2014
Q2 		$1.26M Sell
7,454
-336
-4% -$52.3K 0.04% 387
2014
Q1 		$967K Buy
7,790
+2,280
+41% +$278K 0.04% 433
2013
Q4 		$612K Buy
5,510
+325
+6% +$31K 0.03% 573
2013
Q3 		$469K Buy
5,185
+314
+6% +$28.2K 0.02% 655
2013
Q2 		$410K Buy
+4,871
New +$505K 0.02% 626

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Cambridge Investment Research Advisors's AGN Position: Q1 2015 in Review

Cambridge Investment Research Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 7,996 shares — an estimated $1.7M sold.

Cambridge Investment Research Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.7M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Cambridge Investment Research Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 7,996 Allergan Inc shares in Q1 2015, an estimated $1.7M.
  • Cambridge Investment Research Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's Allergan Inc position peaked at $1.7M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2015, filed 4 May 2015.